| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 1521 |
| 1 | METFORMIN | 62 |
| 2 | METFORMIN ER 500 MG | 60 |
| 3 | METFORMIN ER 750 MG | 60 |
| 4 | AMISULPRIDE | 44 |
| 5 | LORAZEPAM | 43 |
| 6 | OMEPRAZOLE MAGNESIUM | 41 |
| 7 | SERTRALINE | 40 |
| 8 | VALPROATE SODIUM | 40 |
| 9 | OMEPRAZOLE | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOZAPINE | 1521 | 0.0120 |
| 1 | AMISULPRIDE | 44 | 0.0072 |
| 2 | PENICILLIN G POTASSIUM | 4 | 0.0055 |
| 3 | PENICILLIN G | 11 | 0.0047 |
| 4 | VALPROATE SODIUM | 40 | 0.0019 |
| 5 | BECLOMETHASONE DIPROPIONATE | 10 | 0.0017 |
| 6 | TOPOTECAN HYDROCHLORIDE | 4 | 0.0016 |
| 7 | HALOPERIDOL LACTATE | 27 | 0.0011 |
| 8 | LITHIUM CARBONATE | 17 | 0.0010 |
| 9 | LITHIUM | 23 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 1526 |
| 1 | Benzodiazepine [EPC] | 71 |
| 2 | Proton Pump Inhibitor [EPC] | 62 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 53 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 44 |
| 6 | Mood Stabilizer [EPC] | 44 |
| 7 | Anti-epileptic Agent [EPC] | 42 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 35 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 44 | 0.0056 |
| 1 | Atypical Antipsychotic [EPC] | 1526 | 0.0034 |
| 2 | Typical Antipsychotic [EPC] | 26 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 4 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 8 | 0.0004 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 28 | 0.0003 |
| 8 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 9 | Anticholinergic [EPC] | 4 | 0.0002 |